AstraZeneca CEO says drugmaker on hunt for acquisitions
• Soriot, over his decade-long leadership, has quadrupled Astrazeneca’s share price
By Arghyadeep Dutta
Published - Aug 23, 2022, 10:28 AM ET
Last Updated - Jul 18, 2023, 04:30 PM EDT
British drugmaker AstraZeneca is looking to acquire small and mid-sized companies specializing in oncology and cardiovascular treatments, Chief Executive Pascal Soriot told Reuters in an interview on Tuesday.
“We always look for external opportunities,” he said.
Soriot has led the London-listed company and quadrupled its share price within a decade.
“I can keep doing this job for many years,” Soriot told Reuters.
The 63-year-old was once considered the successor to outgoing Chairman Leif Johansson.
But in July, Soriot quashed speculation he was planning to retire any time soon, saying he expected to work with AstraZeneca’s newly announced chairman-designate Michel Demare for many years to come.
Picture Credit: CNBC
ALSO READ:
